EVIDENCE-BASED VALUE OF PD-1 / PD-L1 INHIBITORS IN NSCLC: COMPARISON OF VALUE TO PRICE

被引：0
|
作者：
Doyle, J. J. [1 ]
Wood, B. [1 ]
机构：
[1] IQVIA, New York, NY USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.536
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCP61
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [1] Predictive value of tumor mutational burden for PD-1/PD-L1 inhibitors in NSCLC: A meta-analysis
    Li, Wenjie
    Zhao, Yanjun
    Zhang, Hongjun
    Zheng, Wenying
    Wang, Ruixuan
    Gu, Xing
    MEDICINE, 2023, 102 (40) : E34990
  • [2] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [3] Value assessment of PD-1/ PD-L1 inhibitors in the treatment of oesophageal and gastrointestinal cancers
    Ou, Shun-Long
    Luo, Jing
    Wei, Hua
    Qin, Xiao-Li
    Jiang, Qian
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [4] Prognostic Value of Complement System in NSCLC and its Association with PD-1 and PD-L1 Expression
    Ajona, D.
    Pajares, M. J.
    Freire, J.
    Gomez-Roman, J.
    Martinez-Terroba, E.
    Ortiz-Espinosa, S.
    Lledo, A.
    Arenas-Lazaro, E.
    Agorreta, J.
    Lecanda, F.
    Montuenga, L.
    Pio, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S394 - S394
  • [5] Companion diagnostic assays for PD-1/PD-L1 checkpoint inhibitors in NSCLC
    Jorgensen, Jan Trost
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (02) : 131 - 133
  • [6] Serum CRP Decrease Has Predictive Value for LongTerm Disease Control by PD-1/ PD-L1 Inhibitors in Patients with NSCLC
    Matsuzawa, R.
    Morise, M.
    Tanaka, I.
    Koyama, J.
    Kimura, T.
    Kondoh, Y.
    Hase, T.
    Sakamoto, K.
    Hashimoto, N.
    Hasegawa, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S716 - S716
  • [7] VALUE ASSESSMENT OF HTA DECISIONS FOR PD-1/PD-L1 INHIBITORS IN ONCOLOGY: A NICE PERSPECTIVE
    Bamrara, A.
    Mishra, N.
    Takyar, S.
    VALUE IN HEALTH, 2019, 22 : S506 - S506
  • [8] Expression and prognostic value of PD-1 and PD-L1 in colorectal carcinoma
    Aouadi, R.
    Helal, I.
    Khanchel, F.
    Hedhli, R.
    Ben Brahim, E.
    Jouini, R.
    Debbiche, A. Chadli
    VIRCHOWS ARCHIV, 2024, 485 : S151 - S152
  • [9] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [10] PD-1/PD-L1 Inhibitors in Cervical Cancer
    Liu, Yuncong
    Wu, Li
    Tong, Ruizhan
    Yang, Feiyue
    Yin, Limei
    Li, Mengqian
    You, Liting
    Xue, Jianxin
    Lu, You
    FRONTIERS IN PHARMACOLOGY, 2019, 10
12345